Denali Therapeutics (DNLI) P/BV US GAAP (year values) |
|||||||||
2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
P/BV | ? | 4.22 | 7.93 | 5.63 | 3.35 | 2.86 | 2.01 | ||
Changes by years, y/y, % | +21% | +88% | -29% | -41% | -15% | -4.0% |
Denali Therapeutics. P/BV
Denali Therapeutics. P/BV, changes, %
Denali Therapeutics (DNLI) P/BV US GAAP (quarter values) |
||||||||
2023Q1 | 2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | LTM ? | |||
P/BV | ? | 3.25 | 3.41 | 2.54 | 2.88 | 2.11 | 2.01 | |
Changes by years, y/y, % | -24% | -17% | -46% | -19% | -35% | |||
Changes by quarters, q/q, % | -8% | +5% | -25% | +13% | -27% |